Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
1,050 questions in 42 reviews · Incontinence
current versionsNo studies 391 · 37.2%Ungraded 82 · 7.8%Very low 199 · 19%Low 206 · 19.6%Moderate 150 · 14.3%High 22 · 2.1%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Transvaginal permanent mesh vs native tissue repair Awareness of prolapse (0.5 to 7 years) · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 0.83 [0.73, 0.95] | 17 studies · 2932 participants | Moderate |
Transvaginal biological graft vs native tissue repair Surgery for recurrent prolapse (1 to 2 years) · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 1.15 [0.75, 1.77] | 6 studies · 899 participants | Moderate |
Transvaginal biological graft vs native tissue repair Recurrent prolapse on examination · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 0.96 [0.71, 1.29] | 9 studies · 1278 participants | Low |
Transvaginal biological graft vs native tissue repair Visceral injury · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 0.34 [0.04, 3.26] | 2 studies · 254 participants | Low |
Transvaginal biological graft vs native tissue repair Bladder function · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 12.64 [1.6, 100.06] | 2 studies · 143 participants | Very low |
Transvaginal biological graft vs native tissue repair Painful intercourse ‐ de novo dyspareunia · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 1.3 [0.46, 3.66] | 2 studies · 125 participants | Moderate |
Transvaginal biological graft vs native tissue repair Quality of life · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | no estimate extracted | 3 studies · 112 participants | Very low |
Transvaginal permanent mesh vs native tissue repair Repeat surgery (0.5 to 7 years) · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 1.56 [1.07, 2.26] | 27 studies · 3916 participants | Low |
Transvaginal permanent mesh vs native tissue repair Recurrent prolapse on examination (any compartment) · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 0.42 [0.32, 0.55] | 25 studies · 3680 participants | Very low |
Transvaginal permanent mesh vs native tissue repair Visceral injury · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 3.67 [1.63, 8.28] | 14 studies · 1997 participants | Low |
Transvaginal permanent mesh vs native tissue repair Mesh exposure · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 11.1 [6.81, 18.1] | 26 studies · 2980 participants | Moderate |
Transvaginal permanent mesh vs native tissue repair Bladder function · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 1.5 [1.19, 1.88] | 17 studies · 2001 participants | Moderate |
Transvaginal permanent mesh vs native tissue repair Painful intercourse ‐ de novo dyspareunia · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 1.22 [0.83, 1.79] | 16 studies · 1308 participants | Moderate |
Transvaginal permanent mesh vs native tissue repair Quality of life · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | no estimate extracted | 9 studies · 1365 participants | Very low |
Transvaginal biological graft vs native tissue repair Awareness of prolapse (1 to 3 years) · vaginal prolapse Transvaginal mesh or grafts or native tissue repair for vaginal prolapse (2024) · Cochrane | RR 1.06 [0.73, 1.56] | 8 studies · 1374 participants | Moderate |
Anticholinergics vs placebo Mean change from baseline in condition‐specific quality of lifeScale from: ‐100 to 0 · adults with overactive bladder syndrome Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults (2023) · Cochrane | MD 4.41 | 12 studies · 6804 participants | Low |
Anticholinergics vs placebo Patient perception of cure or improvement · adults with overactive bladder syndrome Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults (2023) · Cochrane | RR 1.38 [1.15, 1.66] | 9 studies · 8457 participants | Moderate |
Anticholinergics vs placebo Mean number of urgency episodes per 24 hours · adults with overactive bladder syndrome Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults (2023) · Cochrane | MD 0.85 | 23 studies · 16875 participants | Moderate |
Anticholinergics vs placebo Adverse events: dry mouth · adults with overactive bladder syndrome Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults (2023) · Cochrane | RR 3.5 [3.26, 3.75] | 66 studies · 38368 participants | Low |
Anticholinergics vs placebo Adverse events:urinary retention · adults with overactive bladder syndrome Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults (2023) · Cochrane | RR 3.52 [2.04, 6.08] | 17 studies · 7862 participants | Low |
Anticholinergics vs placebo Withdrawal due to adverse events · adults with overactive bladder syndrome Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults (2023) · Cochrane | RR 1.37 [1.21, 1.56] | 61 studies · 36943 participants | Low |
Anticholinergics vs placebo Mean number of micturitions per 24 hours · adults with overactive bladder syndrome Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults (2023) · Cochrane | MD 0.85 | 30 studies · 19395 participants | Moderate |
Single‐incision slings vs autologous fascial slings Subjective cure or improvement of urinary incontinence: at 12 months · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | no estimate extracted | NR | No studies |
Single‐incision slings vs retropubic minimally‐invasive slings Number of women with dyspareunia · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | no estimate extracted | NR | No studies |
Single‐incision slings vs retropubic minimally‐invasive slings Number of women with mesh exposure, extrusion or erosion in any area · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 1.55 [0.24, 9.82] | 3 studies · 267 participants | Low |
Single‐incision slings vs retropubic minimally‐invasive slings Number of women with urinary retention · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 0.47 [0.12, 1.84] | 2 studies · 209 participants | Low |
Single‐incision slings vs retropubic minimally‐invasive slings Quality of life: at 12 months · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | no estimate extracted | NR | No studies |
Single‐incision slings vs retropubic minimally‐invasive slings Number of women requiring repeat continence surgery or mesh revision · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 4.19 [0.31, 57.28] | 2 studies · 182 participants | Very low |
Single‐incision slings vs transobturator minimally‐invasive slings Subjective cure or improvement of urinary incontinence: 12 months · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 1 [0.97, 1.03] | 17 studies · 2359 participants | High |
Single‐incision slings vs transobturator minimally‐invasive slings Patient‐reported pain: at more than 24 months · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 0.12 [0.02, 0.68] | 2 studies · 250 participants | Moderate |
Single‐incision slings vs transobturator minimally‐invasive slings Number of women with dyspareunia · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 0.78 [0.41, 1.48] | 8 studies · 810 participants | Moderate |
Single‐incision slings vs transobturator minimally‐invasive slings Number of women with mesh exposure, extrusion or erosion in any area · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 0.61 [0.39, 0.96] | 16 studies · 2378 participants | High |
Single‐incision slings vs transobturator minimally‐invasive slings Number of women with urinary retention · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 0.68 [0.47, 0.97] | 23 studies · 2891 participants | Moderate |
Single‐incision slings vs autologous fascial slings Patient‐reported pain: at more than 24 months · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | no estimate extracted | NR | No studies |
Single‐incision slings vs transobturator minimally‐invasive slings Quality of life: at 12 months · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | SMD 0.24 [0.09, 0.39] | 8 studies · 689 participants | Low |
Single‐incision slings vs transobturator minimally‐invasive slings Number of women requiring repeat continence surgery or mesh revision · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 1.42 [0.94, 2.16] | 13 studies · 1460 participants | Low |
Single‐incision slings vs autologous fascial slings Number of women with dyspareunia · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 1.33 [0.32, 5.53] | 1 study · 70 participants | Low |
Single‐incision slings vs autologous fascial slings Number of women with mesh exposure, extrusion or erosion in any area · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 2 [0.19, 21.06] | 1 study · 70 participants | Low |
Single‐incision slings vs autologous fascial slings Number of women with urinary retention · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | no estimate extracted | NR | No studies |
Single‐incision slings vs autologous fascial slings Quality of life: at 12 months · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | no estimate extracted | NR | No studies |
Single‐incision slings vs autologous fascial slings Number of women requiring repeat continence surgery · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | no estimate extracted | NR | No studies |
Single‐incision slings vs retropubic minimally‐invasive slings Subjective cure or improvement of urinary incontinence: at 12 months · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | RR 0.99 [0.91, 1.07] | 2 studies · 297 participants | Low |
Single‐incision slings vs retropubic minimally‐invasive slings Patient‐reported pain: at more than 24 months · women with urinary incontinence Single‐incision sling operations for urinary incontinence in women (2023) · Cochrane | no estimate extracted | NR | No studies |
Vaginal procedure vs sacral colpopexy (vault prolapse) Awareness of prolapse · women with apical vaginal vault prolapse Surgery for women with apical vaginal prolapse (2023) · Cochrane | RR 2.31 [1.27, 4.21] | 4 studies · 346 participants | Moderate |
Vaginal hysterectomy vs sacral hysteropexy/cervicopexy (uterine prolapse) Surgery for recurrent prolapse · women with apical uterine prolapse Surgery for women with apical vaginal prolapse (2023) · Cochrane | RR 0.85 [0.47, 1.54] | 5 studies · 403 participants | Low |
Vaginal hysterectomy vs sacral hysteropexy/cervicopexy (uterine prolapse) Prolapse on examination (Stage 2 or greater) ‐ Any recurrent prolapse · women with apical uterine prolapse Surgery for women with apical vaginal prolapse (2023) · Cochrane | RR 0.78 [0.54, 1.11] | 2 studies · 230 participants | Moderate |
Vaginal hysterectomy vs sacral hysteropexy/cervicopexy (uterine prolapse) Mesh exposure · women with apical uterine prolapse Surgery for women with apical vaginal prolapse (2023) · Cochrane | RR 1.85 [0.7, 4.87] | 4 studies · 307 participants | Very low |
Vaginal hysterectomy vs sacral hysteropexy/cervicopexy (uterine prolapse) Operating time (minutes) · women with apical uterine prolapse Surgery for women with apical vaginal prolapse (2023) · Cochrane | no estimate extracted | 5 studies · 422 participants | Low |
Vaginal hysterectomy vs sacral hysteropexy/cervicopexy (uterine prolapse) Length of Hospital Stay (days) · women with apical uterine prolapse Surgery for women with apical vaginal prolapse (2023) · Cochrane | no estimate extracted | 5 studies · 422 participants | Very low |
Vaginal hysterectomy vs sacral hysteropexy/cervicopexy (uterine prolapse) Blood loss (mls) · women with apical uterine prolapse Surgery for women with apical vaginal prolapse (2023) · Cochrane | no estimate extracted | 2 studies · 148 participants | Low |